Baxter projects 2026 organic sales growth of 3%–4% and adjusted EPS of $2.05–$2.15 while targeting ~3x net leverage

Baxter Q3 2026 earnings: raised sales and EPS outlook, strong cash flow, and Round Lake changes shape risks.